CBP, FDA seize counterfeit, flavored e-cigarettes valued at over $719K

NewsGuard 100/100 Score

U.S. Customs and Border Protection officers at the Dallas Fort Worth International Airport working in conjunction with agents from the U.S. Food and Drug Administration announced today that they have seized 33,681 units of e-cigarettes with a Manufacturer's Suggested Retail Price of $719,453.

In December 2020, CBP seized 42 separate shipments arriving from China destined to various Texas counties. The shipments included individual disposable flavored e-cigarette cartridges resembling the Puff Bar brand, including Puff XXL and Puff Flow.

As part of an ongoing joint operation with FDA, officers and agents were looking to intercept counterfeit or other violative e-cigarettes, including certain flavored e-cigarettes imported to the U.S. that did not meet the Federal Food, Drug, and Cosmetic Act (FD&C Act) requirements, as amended by the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act).

Many counterfeit, unapproved or unauthorized products are likely produced in unregulated facilities with unverified ingredients posing a serious health concern to consumers. It is especially alarming when these types of counterfeit and unauthorized products find their way into the hands of children as studies indicate. We will continue to take every opportunity to work with our partners at the FDA to intercept and seize products that threaten U.S. consumers."

Timothy Lemaux, CBP Port Director

Tobacco products including e-cigarettes imported or offered for import into the U.S. must comply with all applicable U.S. laws.

"The FDA continues to prioritize enforcement against e-cigarette products, specifically those most appealing and accessible to youth," said Mitch Zeller, J.D., director of the FDA's Center for Tobacco Products. "We are very concerned about how popular these products are with youth. This seizure makes clear to tobacco product manufacturers, retailers and importers that the FDA is keeping a close watch on the marketplace and will hold accountable those companies that violate tobacco laws and regulations."

CBP's trade enforcement mission places a significant emphasis on intercepting illicit products that could harm American consumers. In fiscal year 2020, CBP seized 93,590 units of e-cigarettes that did not meet U.S. federal regulations.

In July 2020, the FDA issued a warning letter to Cool Clouds Distribution Inc. (doing business as Puff Bar), to remove their flavored disposable e-cigarettes and youth-appealing e-liquid products from the market because they do not have the required premarket authorization. These actions are part of the FDA's ongoing, aggressive effort to take action against illegally marketed tobacco products amid the public health crisis of youth e-cigarette use in America, including in 2020, refusing admission into the U.S. of at least 150 entries of electronic nicotine delivery systems products for violations of the FD&C Act.    

"Protecting American consumers from illicit and especially harmful tobacco products, such as counterfeit or flavored e-cigarettes, is of utmost importance to the FDA," said Judy McMeekin, Pharm.D., FDA Associate Commissioner for Regulatory Affairs. "We will continue to investigate and remove from the marketplace products that pose a particular danger to the public health."

While the Puff Bar website appears to have recently stopped online sales and distribution in the U.S, it does not mean that the firm ceased distributing products to other retailers or selling products at brick and mortar retail stores. The website's store locators are still active, indicating that potential consumers can still search for products located for sale at retail stores.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Public health efforts urged to reduce sodium in packaged foods